These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5156335)

  • 1. The effect of macromolecules upon the rates of hydrolysis of aromatic nitrogen mustard derivatives.
    Hopwood WJ; Stock JA
    Chem Biol Interact; 1971 Dec; 4(1):31-9. PubMed ID: 5156335
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, chemistry, and preliminary pharmacology of arsenical nitrogen mustards and structurally related nonalkylating arsenicals.
    Bardos TJ; Datta-Gupta N; Hebborn P
    J Med Chem; 1966 Mar; 9(2):221-7. PubMed ID: 5911802
    [No Abstract]   [Full Text] [Related]  

  • 4. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256.
    Cobb LM; Connors TA; Elson LA; Khan AH; Mitchley BC; Ross WC; Whisson ME
    Biochem Pharmacol; 1969 Jun; 18(6):1519-27. PubMed ID: 4307990
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of the effectiveness of d-glyceraldehyde].
    Brock N; Niekamp T
    Z Krebsforsch; 1965 Jul; 67(1):93-104. PubMed ID: 4221137
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE INFLUENCE ON CARBOHYDRATE METABOLISM OF TUMORS OF CHOMOTHERAPEUTIC DRUGS].
    KROEGER H
    Z Naturwiss Med Grundlagenforsch; 1963 Apr; 1():126-42. PubMed ID: 14159165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
    Brock N
    Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 1. Communication: relationship between chemical structure and pharmacological action.
    Brock N; Kuhlmann J
    Arzneimittelforschung; 1974 Aug; 24(8):1139-49. PubMed ID: 4371234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synthesis and antitumor action of N,N-di(2-chlorethyl)-hydrazines of alpha-aminocarboxylic acid antimetabolites].
    Zakhariev S; Golovinsky E; Stoev S; Maneva L; Aleksiev B
    Pharmazie; 1989 Aug; 44(8):542-4. PubMed ID: 2594824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on compounds with antiblastic activity. XXX. p-(N,N-bis-(beta-chloroethyl)amino)benzylidene derivatives of some cyclopentanones.
    Giuliano R; Ermili A; Artico M; Grundmann E; Bierling R; Steinhoff D
    Farmaco Sci; 1967 Apr; 22(4):258-71. PubMed ID: 5608225
    [No Abstract]   [Full Text] [Related]  

  • 11. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 12. Aryl-2-halogenoalkylamines. XXV. Derivatives of sulphanilamide designed for selective deposition in neoplastic tissue.
    Calvert N; Connors TA; Ross WC
    Eur J Cancer (1965); 1968 Dec; 4(6):627-35. PubMed ID: 5717959
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrogen mustard type derivatives of thiophene and benzo[b]thiophene.
    Shirley DA; Bell GR
    J Med Chem; 1966 Jul; 9(4):607-9. PubMed ID: 5968033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological studies with alkylsulfonyloxyalkyl substituted and chloroethyl substituted oxazaphosphorine-2-oxides. 2. Pharmacological characterization of 2-alkylsulfonyl-oxyalkylamino-oxazaphosphorine-2-oxides including immunological reaction].
    Arzneimittelforschung; 1974 Aug; 24(8):1149-60. PubMed ID: 4371545
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental animal studies on the regional perfusion of tumors of the extremities].
    Brock N; Niekamp T
    Arzneimittelforschung; 1968 Jan; 18(1):1-7. PubMed ID: 5754938
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumour chemotherapy: syntheses of N-phosphorylated nitrogen mustards and related compounds].
    Kao WI; Ho HY; Song CW; Li MM; Cheng BL
    Yao Xue Xue Bao; 1965 Oct; 12(10):672-7. PubMed ID: 5898992
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
    Brock N
    Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme activated anti-tumour agents--III. Hydrolysis of conjugates of p-hydroxyaniline mustard in aqueous solution.
    Workman P; Double JA; Wilman DE
    Biochem Pharmacol; 1976 Nov; 25(21):2347-50. PubMed ID: 999722
    [No Abstract]   [Full Text] [Related]  

  • 20. N4-(2-bromoethyl)-N4-ethylsulfanilamide, a monofunctional nitrogen mustard with antitumor action.
    Hebborn P; Triggle DJ
    J Med Chem; 1965 Jul; 8(4):541-2. PubMed ID: 5899085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.